AME vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

AME

60.9
AI Score
VS
AME Wins

MLAB

62.9
AI Score

Investment Advisor Scores

AME

61score
Recommendation
BUY

MLAB

63score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric AME MLAB Winner
Forward P/E 28.2486 34.4828 AME
PEG Ratio 2.7999 0 Tie
Revenue Growth 15.0% 1.0% AME
Earnings Growth 14.2% -42.4% AME
Tradestie Score 60.9/100 62.9/100 MLAB
Profit Margin 20.0% 1.9% AME
Beta 1.00 1.00 Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

AME 1M: +2.0% · 3M: +3.8% MLAB 1M: -4.0% · 3M: +28.0%

Current Technical Phase

AME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 57

RSI (14): 56.6 · Price: $250.28

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.3% over 20 days), RSI 53

RSI (14): 52.6 · Price: $129.20

Fundamentals Snapshot

Metric AME MLAB
Market Cap — —
Forward P/E 26.2 24.0
Trailing P/E 36.2 147.2
Revenue (TTM) — —
Revenue Growth 0.2% 0.0%
Gross Margin 0.4% 0.6%
Operating Margin 0.3% 0.1%
EPS 6.84 0.85
Dividend Yield 0.01% 0.01%

Frequently Asked Questions

Based on our detailed analysis, AME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.